Trade Summary

9 months ago, Rubric Capital Management LP, serving as 10% owner at Heron Therapeutics, Inc. /De/ (HRTX), purchased 2,387,225 shares at $1.50 per share, for a total transaction value of $3,580,838.00. Following this transaction, Rubric Capital Management LP now holds 29,100,728 shares of HRTX.

This purchase represents a 9.00% increase in Rubric Capital Management LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 8, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, August 12, 2025 at 2:00 PM ET, 4 days after the trade was made.

Heron Therapeutics, Inc. /De/ operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.